AZ's new leukaemia drug approved in the US

06:54 EDT 14 Sep 2018 | pharmaphorum

The FDA has approved a new cancer drug from AstraZeneca, the first medicine to treat a rare and life-threatening form of leukaemia to hit the market for 20 years. Developed by AZ’s MedImmune biologics arm, Lumoxiti (moxetumomab pasudotox-tdfk) is ...

Original Article: AZ's new leukaemia drug approved in the US


More From BioPortfolio on "AZ's new leukaemia drug approved in the US"

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...